Professor, Molecular Pharmacology and Experimental Therapeutics
Mayo Clinic, Minnesota
Keith D. Robertson, Ph.D., Professor, Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic
Dr. Keith Robertson earned his Bachelor’s degree at Cornell University and his Ph.D. at The Johns Hopkins University in Dr. Richard Ambinder’s laboratory. He did postdoctoral training with Dr. Peter Jones at the University of Southern California and with Dr. Alan Wolffe at the National Institutes of Health. His first faculty position was within the intramural program at the NIH followed by the University of Florida and currently the Mayo Clinic, where he is a Professor of Molecular Pharmacology and Experimental Therapeutics. Dr. Robertson has published over 120 manuscripts in the area of cancer epigenetics and his laboratory has been continuously funded by the NIH. He has served on numerous national and international grant review panels and is on the editorial board of the journal Epigenetics. The laboratory uses a combination of basic biochemical methods, cell biology, genome/epigenome engineering, and omics analyses to understand how epigenetic processes like DNA and histone methylation maintain normal cellular growth controls, and when deregulated or mutated in cancer, contribute to tumor initiation and progression.
Disclosure information not submitted.
Tuesday, October 18, 2022
1:30 PM – 2:30 PM ET